Quantcast

Latest Cancer Research Stories

2014-03-20 23:02:41

Researchers at UC Davis have found that the investigational cancer vaccine tecemotide, when administered with the chemotherapeutic cisplatin, boosted immune response and reduced the number of tumors in mice with lung cancer. Sacramento, CA (PRWEB) March 20, 2014 Researchers at UC Davis have found that the investigational cancer vaccine tecemotide, when administered with the chemotherapeutic cisplatin, boosted immune response and reduced the number of tumors in mice with lung cancer. The...

2014-03-20 08:29:42

VANCOUVER, British Columbia and MENLO PARK, Calif., March 20, 2014 /PRNewswire/ -- DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar" and "DelMar Pharma") provided an update as of the quarter ended December 31, 2013 and a summary of progress toward the Company's goals for the year. DelMar also announced an investor conference call to take place today at 1 pm EDT. Details and log-in information will be posted on the website at www.delmarpharma.com in advance of the call....

2014-03-19 16:20:12

Hyundai Hope On Wheels will announce its 2014 Grants Program FOUNTAIN VALLEY, Calif., March 19, 2014 /PRNewswire/ -- Hyundai Hope On Wheels®, a leading contributor to pediatric cancer research nationwide, announced today it will sponsor the Pediatric Cancer Town Hall Meeting at the 105(th) Annual Meeting of the American Association for Cancer Research to be held April 5-9, 2014 in San Diego, Calif. http://photos.prnewswire.com/prnvar/20131002/LA90771LOGO-b The Pediatric Cancer...

2014-03-19 08:30:04

FDNA launches Face2Gene[TM], a search and reference mobile app powered by its proprietary Facial Dysmorphology Novel Analysis technology NEW YORK, March 19, 2014 /PRNewswire/ -- FDNA(R) (http://www.fdna.com) - a pioneer in computer-aided dysmorphology analysis has announced the availability of Face2Gene - a genetic search and reference mobile application powered by the Facial Dysmorphology Novel Analysis technology. Face2Gene facilitates detection of facial...

2014-03-17 08:29:07

HOUSTON, March 17, 2014 /PRNewswire-USNewswire/ -- The University of Texas MD Anderson Cancer Center and MedImmune, the global biologics research and development arm of AstraZeneca, will collaborate through MD Anderson's Moon Shots Program to develop therapies that unleash patients' immune systems to attack their cancers. "Our collaboration with MedImmune, a leader in the field of immunotherapy, will draw on the strengths of both institutions to push ahead for more effective...

2014-03-14 23:25:33

“Patients and their families will now have an easy access to the first American Hospice and Palliative Care Hospital and its extraordinary staff with caring hearts and spirits”, said Wen-Jen Hwu, M.D., Ph.D., Board of Directors and Chairman of Professional Advisory Committee, The University of Texax MD Anderson Cancer Center, Professor, Department of Melanoma Medical Oncology and United States Chairman of Woman in Cancer Research. New Haven, Connecticut (PRWEB) March 14, 2014 The...

2014-03-14 23:25:10

NOVA nominates Rebecca Kamen, Professor of Art, for Professor Emeritus to celebrate 35 years of distinguished service. Kamen's work is recognized for embodying the STEM to STEAM movement, and her approach is celebrated in both the art and scientific communities. McLean, VA (PRWEB) March 14, 2014 Northern Virginia Community College ( NOVA) recently nominated Rebecca Kamen, Professor of Art, for Professor Emeritus to celebrate 35 years of distinguished service, teaching excellence and...

2014-03-13 23:03:24

FDNA will unveil Face2Gene™, a mobile app for research and investigation of genetic syndromes, using facial photos. (PRWEB) March 13, 2014 FDNA® (http://www.fdna.com) – a pioneer in computer-aided dysmorphology analysis is scheduled to exhibit at the 2014 ACMG meeting, booth #915 in Nashville, Tennessee. The company will present its proprietary technology in a scheduled theater presentation and unveil Face2Gene, the first available search and reference mobile application, powered...

2014-03-10 08:30:35

BERGEN, Norway, March 10, 2014 /PRNewswire/ -- NOK 13 million funding secured from the Research Council of Norway BerGenBio AS ("BerGenBio" or the "Company"), an oncology biopharmaceutical company, is pleased to announce the award of a NOK 13 million grant from the Research Council of Norway's User-driven Research based Innovation programme (BIA) to help fund research into novel therapeutics for inhibiting tumor epithelial-mesenchymal transition (EMT), a key...

2014-03-06 13:13:25

Ludwig researchers show that infecting just 1 tumor with a virus could boost the systemic effectiveness of cancer immunotherapy A Ludwig Cancer Research study suggests that the clinical efficacy of checkpoint blockade, a powerful new strategy to harness the immune response to treat cancers, might be dramatically improved if combined with oncolytic virotherapy, an investigational intervention that employs viruses to destroy tumors. Published today in the journal Science Translational...


Word of the Day
vermicular
  • Like a worm in form or movement; vermiform; tortuous or sinuous; also, writhing or wriggling.
  • Like the track or trace of a worm; appearing as if worm-eaten; vermiculate.
  • Marked with fine, close-set, wavy or tortuous lines of color; vermiculated.
  • A form of rusticated masonry which is so wrought as to appear thickly indented with worm-tracks.
This word ultimately comes from the Latin 'vermis,' worm.
Related